A nationwide study has provided new information on the survival rates ...
Ahmedabad-based Zydus Lifesciences has launched Relugolix under t...
Government of Goa has announced renewal of Memorandum of Under...
AstraZeneca India Pharma has launched Trastuzumab deruxtecan, the...
Researchers at the Indian Institute of Technology Madras (II...
Cytelabs, a first-of-its-kind, specialised oncopathology cancer d...
AstraZeneca Pharma India has signed a Memorandum of Understanding (MoU...
The US Food and Drug Administration (FDA) has approved two milestone t...
AstraZeneca Pharma India has inaugurated a dedicated Centre of Excelle...
Redcliffe Labs has expanded its services with the addition of Prostate...
Mumbai-based Sun Pharmaceutical Industries and Ahmedabad-based Zydus L...
A first-of-its-kind study in real-world setting conducted in Indi...
How will the recent launch of Cetuximab and Bevacizumab disrupt ...
Cytelabs, a first-of-its-kind independent and specialised oncopatholog...
HexaHealth, a startup that aims to support quality medical treatment f...
St Judes India, along with the Advanced Centre for Treatment, Research...
AstraZeneca India has announced its entry into rare disease therapy in...
Zydus Hospitals, Ahmedabad, and India Medtronic, a wholly-owned subsid...
